DEA Proposes Increasing Amount of Cannabis, Psychedelics Authorized for Research
Comments on the proposals can be submitted to DEA until Nov. 30. The U.S. Drug
Cannabis News
Pennsylvania House Committee Approves Senate-Passed Bill To Let Medical Marijuana Growers Sell Directly To Patients
A Pennsylvania House committee has approved a Senate-passed bill that would allow all licensed medical
Minor, Nonterpenoid Volatile Compounds Drive the Aroma Differences of Exotic Cannabis
Cannabis sativa L. produces a wide variety of volatile secondary metabolites that contribute to its unique
Lawmakers turn up heat on New York cannabis regulators at hearing
State senators grilled Office of Cannabis Management Executive Director Chris Alexander and other officials on
Denver hit $500 million in marijuana tax revenue. So where does the money go?
Every time someone lights up a joint in Denver, the city government gets a couple
China Manufacturing Tips for Cannabis Brands
We are seeing in an uptick in China-related matters involving cannabis brands. Here are three
Massachusetts Cannabis Businesses File Lawsuit Against the U.S. Attorney General
A handful of cannabis companies recently initiated a lawsuit with U.S. Attorney General Merrick Garland
Russian Astronauts Find Mysterious Holes in International Space Station
Some routine repairs on the International Space Station unveiled something mysterious last week when a
NY cannabis hearing focuses on legal market challenges (Newsletter: October 31, 2023)
POTUS candidate Dean Phillips on marijuana; MA psychedelics ballot signatures; OH legalization polls; Australian drug
DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands
The Drug Enforcement Administration (DEA) is proposing a dramatic increase in its 2023 production quotas